Enveric Biosciences Inc. Company Profile
NASDAQ: ENVBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Enveric Biosciences at a glance
Enveric Biosciences Inc. (NASDAQ: ENVB) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Cambridge, MA. Enveric Biosciences is led by Dr. Joseph Edward Tucker Ph.D. and employs about 5 people. At a market capitalization of $6.7 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0000890821, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Enveric Biosciences do?
Enveric Biosciences, Inc., a biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States. Its lead drug candidate is EB-003, a novel derivative of DMT in preclinical development for mental health indications. The company also develops EVM401 series comprising novel phenylalkylamines and indolethylamines, as well as mescaline-derived compounds to target addiction and neuropsychiatric disorders; and Psybrary, a proprietary library. Enveric Biosciences, Inc. is headquartered in Cambridge, Massachusetts.
Business description based on the company's public filings.
Company information
- Legal name
- Enveric Biosciences Inc.
- Ticker
- NASDAQ: ENVB
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Dr. Joseph Edward Tucker Ph.D.
- Employees
- 5
- Headquarters
- 245 First Street, Cambridge, MA, United States
- Phone
- 617 444 8400
- Website
- enveric.com
- Market cap
- $6.69M
- SEC CIK
- 0000890821
Companies similar to Enveric Biosciences
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| LEXXLexaria Bioscience Corp. | 3.20 | -8.57% | $6.74M | vs ENVB |
| NRSNNeuroSense Therapeutics Ltd. | 3.58 | -6.28% | $6.79M | vs ENVB |
| XCURExicure Inc. | 1.00 | -1.96% | $6.55M | vs ENVB |
| ALZNAlzamend Neuro Inc. | 1.34 | -2.19% | $6.47M | vs ENVB |
| ACXPAcurx Pharmaceuticals Inc. | 1.25 | -3.85% | $6.95M | vs ENVB |
| APREAprea Therapeutics Inc. | 0.5582 | -7.74% | $7.03M | vs ENVB |
| BOLTBolt Biotherapeutics Inc. | 3.65 | +1.39% | $7.03M | vs ENVB |
| SCNXScienture Holdings Inc. | 3.86 | -6.54% | $6.34M | vs ENVB |